Cisplatin-induced metabolome changes in serum: an experimental approach to identify markers for ototoxicity.
Pernilla Videhult PierreJakob HaglöfBirgitta LinderMikael K R EngskogTorbjörn ArvidssonCurt PetterssonAnette FranssonGöran LaurellPublished in: Acta oto-laryngologica (2017)
Cisplatin-treatment caused significant threshold elevations and outer hair cell (OHC) loss in both groups. The ototoxicity was generally lower in group STS, but a significant difference was reached only at 30 kHz (p = .007). Cisplatin treatment altered the metabolite profile significantly and similarly in both groups. A significant inverse correlation was found between L-acetylcarnitine, N-acetylneuraminic acid, ceramide, and cysteinylserine and high frequency hearing loss in group NaCl. The implication of these correlations should be explored in targeted studies.